BioSyntha Technology
2012
FOUNDED
M&A
STATUS
1-10
EMPLOYEES
M&A
LATEST DEAL TYPE
Description
Developer of microbial technology intended to produce biofuels from renewable raw materials. The company offers metabolic pathway engineering, fermentation, biocatalysis process development, agrochemical metabolites and natural product development services, enabling businesses to help produce chemicals and fuels from renewable resources, such as non-food crops and waste.
Primary Industry
Alternative Energy Equipment
Other Industries
Energy Production
Primary Office
- Hertfordshire BioPark
- Broadwater Road
- Welwyn Garden City AL7 3AX
- England, United Kingdom
+44 01707 000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BioSyntha Technology’s full profile, request a free trial.
BioSyntha Technology Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 18-May-2015 | 00.00 | Completed | Generating Revenue | ||
| 2. Early Stage VC | 14-May-2015 | 00.000 | 00.00 | 00.000 | Completed | Generating Revenue |
| 1. Seed Round | 01-Jan-2014 | $490K | $490K | 00000 | Completed | Generating Revenue |
BioSyntha Technology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary 2 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Ordinary 1 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Ordinary | 27,513 | $0.015232 | $0.15 | $0.15 | 1x | $0.15 | 2.23% |
BioSyntha Technology Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 18-May-2015 | 000000000000000000 | Industrial Chemicals |
BioSyntha Technology Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Acidophil | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Esperante Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Midven (Birmingham) | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Oxford Technology Management | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| UK Innovation & Science Seed Fund | Venture Capital | Minority | 000 0000 | 000000 0 |
BioSyntha Technology Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Brian Rudd | Director, Molecular Biology |
2 Former Executives
You’re viewing 1 of 3 executives. Get the full list »